OK


SEARCH
USA
Incyte
  • Our Company
  • What We Do
  • FOR Investors
  • Incyte News
  • Join Our Team
  • Incyte Involved
  • contact us
  • Our Company
    • OUR COMPANY OVERVIEW
    • OUR LEADERSHIP
    • OUR COMMUNITY
    • OUR COMMITMENT
    • COMPLIANCE & TRANSPARENCY
  • What We Do
    • WHAT WE DO OVERVIEW
    • DISCOVERY & DEVELOPMENT
    • PARTNERSHIPS
    • THERAPIES & SUPPORT
    • Portfolio
    • Clinical Trials
  • FOR Investors
    • For Investors Overview
    • Events & Presentations
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Investor Q & A
    • Investor Contacts
  • Incyte News
    • INCYTE NEWS OVERVIEW
    • Company Statements
    • E-MAIL ALERTS
    • RSS FEEDS
    • Media Contact
  • Join Our Team
    • JOIN OUR TEAM OVERVIEW
    • JOB OPPORTUNITIES
  • Incyte Involved
  • contact us
    • CONTACT US OVERVIEW
    • OUR LOCATIONS
    • medical information

Close

Incyte International Locations

NORTH AMERICA—
HEADQUARTERS

FINLAND

JAPAN

SWEDEN

EUROPE—
HEADQUARTERS

FRANCE

THE NETHERLANDS

SWITZERLAND

AUSTRIA

GERMANY

NORWAY

UNITED KINGDOM

DENMARK

ITALY

SPAIN

EXPLORE OUR PORTFOLIO Focused on transforming the treatment of cancer and other conditions with innovative new therapies.
Listen to our Q3 2019 earnings callQ3 2019 Earnings Call
READ OUR LATEST PRESS RELEASES Explore our latest press releases to see what’s happening at Incyte.
BROWSE JOB OPPORTUNITIES Help us deliver on our mission to make a real difference for patients with cancer.
Incyte
  • Legal Notice
  • Privacy
  • Cookies
  • Opt Out
  • Site Map
© 2012- 2019 Incyte Corporation. All Rights Reserved.

Connect with us:

Twitter logo Twitter logo LinkedIn logo LinkedIn logo Facebook logo Facebook logo Youtube logo Youtube logo
  • Legal Notice
  • Privacy
  • Cookies
  • Opt Out
  • Site Map

Connect with us: Twitter logo Twitter logo LinkedIn logo LinkedIn logo Facebook logo Facebook logo Youtube logo Youtube logo

incyte logo
© 2012- 2019 Incyte Corporation. All Rights Reserved.